Guidance for Applicants

The Cure Parkinson’s Trust (CPT) funds and facilitates laboratory or clinical research projects with the potential to advance knowledge that might lead to a cure for Parkinson’s disease. We have a particular interest in projects that show the potential to slow, stop, reverse the progression of Parkinson's disease with a preference for projects and trials that are likely to lead to clinical translation within 5 years. There are many other legitimate areas of research into Parkinson’s that do not fall into these categories and are therefore not within the remit of CPT. We do, however, welcome enquiries from researchers who seek clarification on the suitability of projects CPT would consider for funding. CPT was founded and is led by people with Parkinson’s which means that patient experience informs all our work. 


  • Projects can be pre-clinical or clinical but must demonstrate clearly how the work moves us closer to a cure. 

  • The project should position the work within a time-frame that identifies what steps are needed to develop this work as a tangible treatment for people with Parkinson’s. 

  • Projects should be milestone driven with clear deliverables.

We are a member of the Association of Medical Research Charities (AMRC) which is recognised as a quality mark demonstrating that vigorous peer review** processes are in place ensuring that only the highest quality of research is supported. 

** In 2015 we funded 21% of the projects submitted to us, or 53% of the projects which were sent for peer review - which meant the committee approved funding for £1,294,611 for research 

The Process

Applicants for grant funding are invited to submit their full proposal including budgets using the relevant forms (see the Applications Forms section below). Applications will be considered according to a number of criteria including their appropriateness to the central aim of The Cure Parkinson's Trust (CPT) i.e. their proximity to cure, originality, the potential clinical impact and achievability.

If the proposed project is considered appropriate to the charity’s objectives, it will first undergo a process of internal evaluation. The proposal is then sent for external peer review. At least two detailed external peer reviews are sought using CPT's external peer review protocol completed by our advisory panel and other acknowledged world experts in Parkinson’s research and treatment. If a compound is part of a proposal, an external commercial review may also be sought by trustees. Following external peer review, the proposed project application is then reviewed by the research committee (see below). The research committee prioritises and makes recommendations to the board of trustees which in turn make final funding decisions.

Application Forms

Applicants are invited to submit a full proposal, including budgets - please email for an application form or down load and print this form.  

If the project features a drug, please also complete the Drug CV Form.

Our research committee meets four times a year in February, May, September and November. Application deadlines for 2016 are:

5th May 2016

1st August 2016

27th October 2016 - (We have received an unprecedented number of applications for the October 2016 deadline.  We would kindly remind all applicants to ensure that proposals fit within CPT's funding remit before applying.)

You may find it useful to download and print further information and guidelines for grant funding applications.

Please also read our Terms and Conditions for Grant Funding.

The Research Committee

Dr John Scadding OBE, Our research committee is chaired by Dr Scadding, Emeritus Dean of The Royal Society of Medicine and Honorary Consultant Neurologist to the National Hospital for Neurology and Neurosurgery, London.

Professor Tom Foltynie, Consultant Neurologist at The National Hospital for Neurology & Neurosurgery. Dr Foltynie is involved in trials of Duodopa, Exenatide and cell transplantation.

Dr Mike Hurley, senior researcher at Imperial College, London who has been a strong supporter and loyal advisor to the charity since it began.

Dr. Tilo Kunath, Senior Research Fellow and Group Leader at MRC Centre for Regenerative Medicine

Professor Andrew Lees, In 2011 Professor Lees was named the most highly cited Parkinson’s researcher. He is widely regarded as one of the most influential Parkinson’s experts in the world.

Dr Jon Stamford who attends our research committee meetings both as a neuroscientist and as a person with Parkinson’s, he is co-founder of Parkinson's Movement.

Dr Alan Whone, Consultant Senior Lecturer in Movement Disorders Neurology at the University of Bristol and Southmead Hospital, Bristol. 

Professor Alasdair Coles, Honorary Consultant Neurologist, Cambridge University Hospitals. Alasdair mainly treats people with multiple sclerosis also seeing people with general neurological problems and those with inflammatory diseases of the brain. 

Dr John Warren, is a clinical scientist who established Medicines Assessment Ltd as a pharmaceutical consultancy in 2011. He advises multiple pharmaceutical companies on clinical development.

Dr Richard Wyse, Dr Joy Duffen, Dr Jon Stamford, Tom Isaacs and Helen Matthews - The Cure Parkinson's Trust

Click here for more details about our committee members